Eric Hsu
Overview
Eric Hsu received an average of $316K in total compensation, including $244K in salary, at InMed Pharmaceuticals from 2021 to 2024.
2024InMed PharmaceuticalsSenior Vice President, Preclinical Research & Development
2023InMed PharmaceuticalsSenior Vice President, Preclinical Research & Development
2022InMed PharmaceuticalsSenior Vice President, PreClinical R&D
2021InMed PharmaceuticalsSenior Vice President, PreClinical R&D
Source: SEC filings on October 28, 2024 and October 28, 2022.
Related executives
We found six more executives who work or worked at InMed Pharmaceuticals.
Eric Adams
InMed Pharmaceuticals
Chief Executive Officer
Michael Woudenberg
InMed Pharmaceuticals
Chief Operating Officer
Alexandra Mancini
InMed Pharmaceuticals
Senior Vice President, Clinical & Regulatory Affairs
Netta Jagpal
InMed Pharmaceuticals
Chief Financial Officer
Jonathan Tegge
InMed Pharmaceuticals
Chief Financial Officer
Bruce Colwill
InMed Pharmaceuticals
Chief Financial Officer
News
InMed Pharmaceuticals CEO Eric Adams' 2024 pay rises 13% to $415K
October 28, 2024
InMed Pharmaceuticals CEO Eric Adams' 2023 pay falls 22% to $368K
October 27, 2023
InMed Pharmaceuticals CEO Eric Adams' 2022 pay falls 36% to $468K
October 28, 2022
InMed Pharmaceuticals CEO Eric Adams' 2021 pay jumps 73% to $735K
October 28, 2021